Insider filings
Viking Therapeutics, Inc. (VKTX)
Free on iOS and Android.
About Viking Therapeutics, Inc.
from the company's filings and listing, as of Oct 25, 2026- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Chief executive
- Brian Lian
- Employees
- 65
- Listed since
- Apr 28, 2015
- Market value
- $3.1B
- Price to earnings (12 mo)
- -
- Net income per share, as reported (12 mo)
- -$4.61
- Dividend yield
- -
Earnings
6 reported quarters · next on Oct 28, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Jul 29, 2026 | -$1.10 | -$1.23 | n/a | n/a | EPS beat, GAAPRevenue n/a |
| Q1 FY2026reported Apr 29, 2026 | -$1.37 | -$1.01 | n/a | n/a | EPS miss, GAAPRevenue n/a |
| Q4 FY2025reported Feb 11, 2026 | -$1.38 | -$0.89 | n/a | $1.9M | EPS missRevenue n/a |
| Q3 FY2025reported Oct 22, 2025 | -$0.81 | -$0.70 | n/a | n/a | EPS miss, GAAPRevenue n/a |
| Q2 FY2025reported Jul 23, 2025 | -$0.58 | -$0.44 | n/a | n/a | EPS miss, GAAPRevenue n/a |
| Q1 FY2025reported Apr 23, 2025 | -$0.41 | -$0.34 | n/a | n/a | EPS miss, GAAPRevenue n/a |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for fiscal 2025 · proxy filed Apr 1, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Brian Lian, Ph.D.Chief Executive Officer | $672K | $17.8M | $2.8M | $21.3M |
| Marianne ManciniChief Operating Officer | $540K | $3.2M | $1.4M | $5.2M |
| Greg ZanteChief Financial Officer | $521K | $3.2M | $1.4M | $5.1M |
The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. Executives who have since left are not shown. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Shares vs prior qtr | % of shares out |
|---|---|---|---|---|
| FMR LLC | $247.2M | 6,335,756 | +5.2% | 5.47% |
| BlackRock, Inc. | $241.5M | 6,189,649 | -10.0% | 5.34% |
| State Street Corp | $218.7M | 5,606,394 | +27.5% | 4.85% |
| Vanguard Capital Management LLC | $197.1M | 5,053,663 | +0.8% | 4.36% |
| Vanguard Portfolio Management LLC | $174.9M | 4,484,263 | +0.4% | 3.87% |
| Two Sigma Investments, LP | $153.6M | 3,937,414 | -11.2% | 3.40% |
| Morgan Stanley | $136.0M | 3,486,040 | +15.7% | 3.01% |
| Ameriprise Financial Inc | $84.1M | 2,156,083 | +28.4% | 1.86% |
| Geode Capital Management, LLC | $81.9M | 2,097,981 | +0.8% | 1.81% |
| American Century Companies Inc | $70.8M | 1,816,050 | -12.6% | 1.57% |
| D. E. Shaw & Co., Inc. | $62.6M | 1,605,994 | -4.2% | 1.39% |
| BNP Paribas Arbitrage, SNC | $38.3M | 981,700 | +81.6% | 0.85% |
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Open-market insider trades
6 filings shown · newest filing first| Insider | Action | Shares | Price | Value | Trade date | Delay (business days) |
|---|---|---|---|---|---|---|
| Marianna ManciniChief Operating Officer | Sold | 18,217 | $33.47 | $610K | Jul 29, 2026filed Jul 29, 2026 | 0d |
| Greg ZanteChief Financial Officer | Sold | 21,217 | $33.47 | $710K | Jul 29, 2026filed Jul 29, 2026 | 0d |
| Brian LianPresident & CEO | Sold | 148,517 | $33.32 | $4.9M | Jul 29, 2026filed Jul 29, 2026 | 0d |
| Neil William AubuchonChief Commercial Officer | Bought | 4,475 | $33.50 | $150K | Mar 10, 2026filed Mar 10, 2026 | 0d |
| Marianna ManciniChief Operating Officer | Sold · 2 lines | 45,561 | $32.62 | $1.5M | Jan 5, 2026filed Jan 5, 2026 | 0d |
| Greg ZanteChief Financial Officer | Sold · 4 lines | 57,661 | $32.90 | $1.9M | Jan 5, 2026filed Jan 5, 2026 | 0d |
One row is one filing, newest filing first. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count. The delay counts business days from the trade to the filing, the unit of Form 4's two business day deadline: weekends and federal holidays are skipped. How the filing itself works is explained in our guide to Form 4.
Other Form 4 activity (8)
| Insider | Event | Shares | Date |
|---|---|---|---|
| Dorothy Elizabeth Kelly-GemmellDirector | Stock award | 47,133 | Aug 1, 2026 |
| Marianna ManciniChief Operating Officer | Stock award | 31,667 | Jul 28, 2026 |
| Greg ZanteChief Financial Officer | Stock award | 31,667 | Jul 28, 2026 |
| Brian LianPresident & CEO | Stock award | 221,667 | Jul 28, 2026 |
| Hubert C. ChenChief Medical Officer | Stock award | 190,000 | Jun 1, 2026 |
| Neil William AubuchonChief Commercial Officer | Stock award | 180,000 | Jan 12, 2026 |
| Marianna ManciniChief Operating Officer | Stock award | 73,049 | Jan 2, 2026 |
| Greg ZanteChief Financial Officer | Stock award | 164,049 | Jan 2, 2026 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Questions
Are insiders buying or selling VKTX?
Across the 6 most recent open-market filings shown here, 1 was a purchase and 5 were sales.
How quickly are VKTX trades disclosed?
Insider filings on this page reached the public a median of 0 business days after the transaction (weekends and federal holidays skipped), against the two business days Form 4 allows.
How to read a Form 4
A DECISION THE INSIDER MADE
COMPENSATION PLUMBING
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 26, 2026.